VISTAGEN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.52 USD | 0.00% |
|
-7.12% | -31.52% |
| Jun. 11 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
| Jun. 11 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-11 | 2024-06-12 | 2024-06-13 | 2024-06-14 | |
|---|---|---|---|---|
| Last | 3.77 $ | 3.69 $ | 3.52 $ | 3.52 $ |
| Volume | 134 820 | 100 994 | 150 245 | 307 332 |
| Change | +2.45% | -2.12% | -4.61% | 0.00% |
| Opening | 3.69 | 3.80 | 3.51 | 3.50 |
| High | 3.78 | 3.98 | 3.70 | 3.55 |
| Low | 3.61 | 3.66 | 3.51 | 3.37 |
Performance
| 1 week | -7.12% | ||
| Current month | -8.81% | ||
| 1 month | -23.31% | ||
| 3 months | -13.09% | ||
| 6 months | -29.32% | ||
| Current year | -31.52% | ||
| 1 year | +69.23% | ||
| 3 years | -95.76% | ||
| 5 years | -84.85% | ||
| 10 years | -99.08% |
Volumes
marketsDaily volume
307 324
Estimated daily volume
307 324
Avg. Volume 20 sessions
123 606
Daily volume ratio
2.49
Avg. Volume 20 sessions USD
435 093.12
Record volume 1
53 904 142
Record volume 2
14 946 047
Record volume 3
10 393 724
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
95 128 735
Net sales (USD)
1 064 000
Number of employees
37
Sales / Employee (USD)
28 757
Free-Float
99.79 %
Free-Float capitalization (USD)
94 940 925
Average Daily Capital Traded
0.46%
Highs and lows
1 week
3.37
3.98
1 month
3.374.57
Current year
3.375.86
1 year
1.6224.71
3 years
1.62106.50
5 years
1.62106.50
10 years
1.62495.00
Indicators
Moving average 5 days
3.64
Moving average 20 days
4.01
Moving average 50 days
4.46
Moving average 100 days
4.59
Price spread / (MMA5)
+3.30%
Price spread / (MMA20)
+13.82%
Price spread / (MMA50)
+26.75%
Price spread / (MMA100)
+30.38%
STIM
RSI 9 days
18.98
RSI 14 days
24.01
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | -7.12% | -31.52% | +69.23% | 95.13M | ||
| +0.35% | -0.48% | +18.15% | +37.71% | 124B | ||
| +0.97% | +3.35% | +18.02% | +32.37% | 112B | ||
| +0.64% | +1.78% | +5.07% | +0.03% | 22.94B | ||
| -4.08% | -8.23% | -12.75% | -18.51% | 22.22B | ||
| -2.28% | +3.98% | -9.86% | -19.13% | 17.02B | ||
| +0.47% | -5.05% | -14.97% | -30.19% | 16.88B | ||
| -2.89% | +3.09% | -39.94% | -38.36% | 16.87B | ||
| -0.59% | +0.36% | +2.80% | +39.86% | 13.63B | ||
| -1.73% | -0.39% | +27.39% | -6.66% | 11.61B | ||
| +3.72% | +12.44% | +106.26% | +219.44% | 10.31B | ||
| -1.45% | +2.78% | +16.15% | +39.89% | 7.94B | ||
| -2.79% | -6.85% | -29.45% | -40.42% | 7.74B | ||
| -0.13% | +3.79% | -2.04% | +17.40% | 7.57B | ||
| -0.16% | -6.95% | +1.34% | +38.05% | 7.32B | ||
| -1.00% | -0.64% | -9.38% | +13.82% | 6.33B | ||
| Average | -0.68% | -0.26% | +2.83% | +22.16% | ||
| Weighted average by Cap. | -0.09% | +0.69% | +10.60% | +23.84% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
159d0b1799c3e8c4b5fd8f0f34b8531.HqPJN4zxnHHEnTNxJbbBx2NNQPX6cp530HrqpGbAOd0.Xc-sdr2FqCCK21tEUdGHsyIMD8evQaZGijWG0weHDu9H54RuxLzzEqarcg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 3.52 | 3,208 | 291,688 |
| 03:59:54 pm | 3.52 | 100 | 288,480 |
| 03:59:54 pm | 3.52 | 107 | 288,380 |
| 03:59:54 pm | 3.52 | 394 | 288,273 |
| 03:59:54 pm | 3.52 | 100 | 287,879 |
| 03:59:53 pm | 3.49 | 325 | 287,779 |
| 03:59:45 pm | 3.51 | 100 | 287,454 |
| 03:59:27 pm | 3.51 | 200 | 287,354 |
| 03:58:53 pm | 3.508 | 200 | 287,154 |
| 03:58:53 pm | 3.51 | 200 | 286,954 |
Monthly variations
Annual change
| 2024 | -31.52% | ||
| 2023 | +66.34% | ||
| 2022 | -94.72% | ||
| 2021 | +0.52% | ||
| 2020 | +181.28% | ||
| 2019 | -54.02% | ||
| 2018 | +34.72% | ||
| 2017 | -70.15% | ||
| 2016 | -62.09% | ||
| 2015 | +15.76% | ||
| 2014 | +1.19% | ||
| 2013 | -42.47% | ||
| 2012 | -76.07% | ||
| 2011 | +24.49% |
- Stock Market
- Equities
- VTGN Stock
- Quotes Vistagen Therapeutics, Inc.
